Association study between two novel single nucleotide polymorphisms and sporadic Parkinson's disease in Chinese Han population

Neuroscience Letters

Volumn 517, Issue 1, 2012, Pages 56-59

  Li, Kai ^a   Tang, Bei sha ^a,b,c   Yu, Ri li ^a   Lv, Zhan yun ^a   Sun, Qi ying ^a   Li, Qian ^a   Xia, Kun ^b   Yan, Xin xiang ^a,c   Guo, Ji feng ^a,c  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b State Key Laboratory of Medical Genetics   (China)

^c CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Rs11868035; Rs6812193; Single nucleotide polymorphism; Sporadic Parkinson's disease

Indexed keywords

ADULT; AGE DISTRIBUTION; ARTICLE; CASE CONTROL STUDY; CHINESE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PARKINSON DISEASE; POLYMERASE CHAIN REACTION; POPULATION RESEARCH; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; CHILD; CHINA; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HUMANS; MALE; MIDDLE AGED; PARKINSON DISEASE; POLYMORPHISM, SINGLE NUCLEOTIDE; YOUNG ADULT;

EID: 84860562258     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2012.04.024     Document Type: Article

References (22)

1. Berkovic S.F., Dibbens L.M., Oshlack A., Silver J.D., Katerelos M., Vears D.F., Lullmann-Rauch R., Blanz J., Zhang K.W., Stankovich J., Kalnins R.M., Dowling J.P., Andermann E., Andermann F., Faldini E., D'Hooge R., Vadlamudi L., Macdonell R.A., Hodgson B.L., Bayly M.A., Savige J., Mulley J.C., Smyth G.K., Power D.A., Saftig P., Bahlo M. Array-based gene discovery with three unrelated subjects shows SCARB2/LIMP-2 deficiency causes myoclonus epilepsy and glomerulosclerosis. American Journal of Human Genetics 2008, 82:673-684. (add).
2. Brown M.S., Goldstein J.L. The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor. Cell 1997, 89:331-340.
3. de Lau L.M., Giesbergen P.C., de Rijk M.C., Hofman A., Koudstaal P.J., Breteler M.M. Incidence of parkinsonism and Parkinson disease in a general population: the Rotterdam Study. Neurology 2004, 63:1240-1244.
4. Do C.B., Tung J.Y., Dorfman E., Kiefer A.K., Drabant E.M., Francke U., Mountain J.L., Goldman S.M., Tanner C.M., Langston J.W., Wojcicki A., Eriksson N. Web-based genome-wide association study identifies two novel loci and a substantial genetic component for Parkinson's disease. PLoS Genetics 2011, 7:e1002141.
5. Edwards T.L., Scott W.K., Almonte C., Burt A., Powell E.H., Beecham G.W., Wang L., Zuchner S., Konidari I., Wang G., Singer C., Nahab F., Scott B., Stajich J.M., Pericak-Vance M., Haines J., Vance J.M., Martin E.R. Genome-wide association study confirms SNPs in SNCA and the MAPT region as common risk factors for Parkinson disease. Annals of Human Genetics 2010, 74:97-109.
6. Eriksson N., Macpherson J.M., Tung J.Y., Hon L.S., Naughton B., Saxonov S., Avey L., Wojcicki A., Pe'Er I., Mountain J. Web-based, participant-driven studies yield novel genetic associations for common traits. PLoS Genetics 2010, 6:e1000993.
7. Hu F.Y., Hu W.B., Liu L., Yu L.H., Xi J., He X.H., Zhu M.R., Liu Z.L., Xu Y.M. Lack of replication of a previously reported association between polymorphism in the 3'UTR of the alpha-synuclein gene and Parkinson's disease in Chinese subjects. Neuroscience Letters 2010, 479:31-33.
8. Hughes A.J., Daniel S.E., Kilford L., Lees A.J. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. Journal of Neurology, Neurosurgery and Psychiatry 1992, 55:181-184.
9. Jostins L. Inferring Genotyping Error Rates From Genotyped Trios 2011, Arxiv preprint arXiv, pp. 1109-1462.
10. Kuronita T., Eskelinen E.L., Fujita H., Saftig P., Himeno M., Tanaka Y. A role for the lysosomal membrane protein LGP85 in the biogenesis and maintenance of endosomal and lysosomal morphology. Journal of Cell Science 2002, 115:4117-4131. (add).
11. Lill C.M., Roehr J.T., McQueen M.B., Kavvoura F., Bagade S., Schjeide B.M.M., Schjeide L., Meissner E., Zauft U., Allen N.C., Tanzi R., Khoury M.J., Ioannidis J.P.A., Bertram L. The PDGene Database, Alzheimer Research Forum 2011, Available from: http://www.pdgene.org/ (accessed 24.12.11).
12. Moore D.J., West A.B., Dawson V.L., Dawson T.M. Molecular pathophysiology of Parkinson's disease. Annual Review of Neuroscience 2005, 28:57-87.
13. Nalls M.A., Plagnol V., Hernandez D.G., Sharma M., Sheerin U.M., Saad M., Simon-Sanchez J., Schulte C., Lesage S., Sveinbjornsdottir S., Stefansson K., Martinez M., Hardy J., Heutink P., Brice A., Gasser T., Singleton A.B., Wood N.W. Imputation of sequence variants for identification of genetic risks for Parkinson's disease: a meta-analysis of genome-wide association studies. Lancet 2011, 377:641-649.
14. Satake W., Nakabayashi Y., Mizuta I., Hirota Y., Ito C., Kubo M., Kawaguchi T., Tsunoda T., Watanabe M., Takeda A., Tomiyama H., Nakashima K., Hasegawa K., Obata F., Yoshikawa T., Kawakami H., Sakoda S., Yamamoto M., Hattori N., Murata M., Nakamura Y., Toda T. Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson's disease. Nature Genetics 2009, 41:1303-1307.
15. Shults C.W. Lewy bodies. Proceedings of the National Academy of Sciences of the United States of America 2006, 103:1661-1668.
16. Simon-Sanchez J., Schulte C., Bras J.M., Sharma M., Gibbs J.R., Berg D., Paisan-Ruiz C., Lichtner P., Scholz S.W., Hernandez D.G., Kruger R., Federoff M., Klein C., Goate A., Perlmutter J., Bonin M., Nalls M.A., Illig T., Gieger C., Houlden H., Steffens M., Okun M.S., Racette B.A., Cookson M.R., Foote K.D., Fernandez H.H., Traynor B.J., Schreiber S., Arepalli S., Zonozi R., Gwinn K., van der Brug M., Lopez G., Chanock S.J., Schatzkin A., Park Y., Hollenbeck A., Gao J., Huang X., Wood N.W., Lorenz D., Deuschl G., Chen H., Riess O., Hardy J.A., Singleton A.B., Gasser T. Genome-wide association study reveals genetic risk underlying Parkinson's disease. Nature Genetics 2009, 41:1308-1312.
17. Spencer C.C., Plagnol V., Strange A., Gardner M., Paisan-Ruiz C., Band G., Barker R.A., Bellenguez C., Bhatia K., Blackburn H., Blackwell J.M., Bramon E., Brown M.A., Brown M.A., Burn D., Casas J.P., Chinnery P.F., Clarke C.E., Corvin A., Craddock N., Deloukas P., Edkins S., Evans J., Freeman C., Gray E., Hardy J., Hudson G., Hunt S., Jankowski J., Langford C., Lees A.J., Markus H.S., Mathew C.G., McCarthy M.I., Morrison K.E., Palmer C.N., Pearson J.P., Peltonen L., Pirinen M., Plomin R., Potter S., Rautanen A., Sawcer S.J., Su Z., Trembath R.C., Viswanathan A.C., Williams N.W., Morris H.R., Donnelly P., Wood N.W. Dissection of the genetics of Parkinson's disease identifies an additional association 5' of SNCA and multiple associated haplotypes at 17q21. Human Molecular Genetics 2011, 20:345-353.
18. Taghibiglou C., Martin H.G., Lai T.W., Cho T., Prasad S., Kojic L., Lu J., Liu Y., Lo E., Zhang S., Wu J.Z., Li Y.P., Wen Y.H., Imm J.H., Cynader M.S., Wang Y.T. Role of NMDA receptor-dependent activation of SREBP1 in excitotoxic and ischemic neuronal injuries. Nature Medicine 2009, 15:1399-1406.
19. Tsuji S., Choudary P.V., Martin B.M., Stubblefield B.K., Mayor J.A., Barranger J.A., Ginns E.I. A mutation in the human glucocerebrosidase gene in neuronopathic Gaucher's disease. New England Journal of Medicine 1987, 316:570-575.
20. Van Den Eeden S.K., Tanner C.M., Bernstein A.L., Fross R.D., Leimpeter A., Bloch D.A., Nelson L.M. Incidence of Parkinson's disease: variation by age, gender, and race/ethnicity. American Journal of Epidemiology 2003, 157:1015-1022.
21. Velayati A., Depaolo J., Gupta N., Choi J.H., Moaven N., Westbroek W., Goker-Alpan O., Goldin E., Stubblefield B.K., Kolodny E., Tayebi N., Sidransky E. A mutation in SCARB2 is a modifier in gaucher disease. Human Mutation 2011, 32:1232-1238.
22. Yokoyama C., Wang X., Briggs M.R., Admon A., Wu J., Hua X., Goldstein J.L., Brown M.S. SREBP-1, a basic-helix-loop-helix-leucine zipper protein that controls transcription of the low density lipoprotein receptor gene. Cell 1993, 75:187-197.